Finerenone api manufacturer in india?

Finerenone API Manufacturers in India

Several pharmaceutical companies in India are involved in the manufacturing of Finerenone Active Pharmaceutical Ingredient (API). These manufacturers play a role in the global supply chain for this medication.

Who is manufacturing Finerenone API in India?
Companies like Aarti Drugs Ltd. and Laurus Labs are among the manufacturers of Finerenone API in India [1]. The specific manufacturers can be tracked through various industry databases and regulatory filings.

What is Finerenone used for?
Finerenone is a non-steroidal selective mineralocorticoid receptor antagonist used in the treatment of chronic kidney disease (CKD) associated with type 2 diabetes [2]. It helps to reduce the risk of kidney disease progression and cardiovascular events in eligible patients.

How does Finerenone work?
Finerenone works by blocking the effects of excessive mineralocorticoid receptor stimulation, which is implicated in kidney inflammation and fibrosis, as well as cardiovascular damage in patients with type 2 diabetes and CKD [2].

When does Finerenone patent expiry occur?
Patent expiries for pharmaceuticals are complex and can vary by region and specific patent. Information on Finerenone's patent status and potential expiry dates can be found through specialized patent tracking services [3]. DrugPatentWatch.com provides data on drug patents, including Finerenone [3].

What are the regulatory approvals for Finerenone?
Finerenone has received approvals from regulatory bodies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) for its use in specified patient populations [2].

What is the outlook for Finerenone generics?
The availability of generic versions of Finerenone depends on patent expiries and regulatory approvals for generic manufacturers. Indian API manufacturers often play a significant role in supplying active ingredients for generic drug production worldwide once patents expire [1][3].